Rajan Kulkarni

Rajan Kulkarni is a Professor of Dermatology in the School of Medicine at Oregon Health & Science University. His research focuses on melanoma biology, cancer immunotherapy, and tumor heterogeneity, with recent work employing single-cell resolution to characterize cutaneous immune-related adverse events and investigating chronotherapy’s role in immune checkpoint inhibitor efficacy. He has published on mesoscale tissue modules in *Cell* and dual MIF/PD-1 inhibition for improved immunotherapy responses in *JCI Insight*. His funded projects include evaluating aneuploidy-driven resistance to BRAFi/MEKi therapy and using circulating tumor cells to assess treatment response in melanoma.